Global Non-Steroidal Anti-Inflammatory Drugs Supply, Demand and Key Producers, 2023-2029
The global Non-Steroidal Anti-Inflammatory Drugs market size is expected to reach $ 30080 million by 2029, rising at a market growth of 5.1% CAGR during the forecast period (2023-2029).
Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
This report studies the global Non-Steroidal Anti-Inflammatory Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Steroidal Anti-Inflammatory Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Steroidal Anti-Inflammatory Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-Steroidal Anti-Inflammatory Drugs total market, 2018-2029, (USD Million)
Global Non-Steroidal Anti-Inflammatory Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Non-Steroidal Anti-Inflammatory Drugs total market, key domestic companies and share, (USD Million)
Global Non-Steroidal Anti-Inflammatory Drugs revenue by player and market share 2018-2023, (USD Million)
Global Non-Steroidal Anti-Inflammatory Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Non-Steroidal Anti-Inflammatory Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Non-Steroidal Anti-Inflammatory Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc. and Merck & Co., Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-Steroidal Anti-Inflammatory Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Non-Steroidal Anti-Inflammatory Drugs Market, By Region:
1. How big is the global Non-Steroidal Anti-Inflammatory Drugs market?
2. What is the demand of the global Non-Steroidal Anti-Inflammatory Drugs market?
3. What is the year over year growth of the global Non-Steroidal Anti-Inflammatory Drugs market?
4. What is the total value of the global Non-Steroidal Anti-Inflammatory Drugs market?
5. Who are the major players in the global Non-Steroidal Anti-Inflammatory Drugs market?
6. What are the growth factors driving the market demand?
Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
This report studies the global Non-Steroidal Anti-Inflammatory Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Steroidal Anti-Inflammatory Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Steroidal Anti-Inflammatory Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-Steroidal Anti-Inflammatory Drugs total market, 2018-2029, (USD Million)
Global Non-Steroidal Anti-Inflammatory Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Non-Steroidal Anti-Inflammatory Drugs total market, key domestic companies and share, (USD Million)
Global Non-Steroidal Anti-Inflammatory Drugs revenue by player and market share 2018-2023, (USD Million)
Global Non-Steroidal Anti-Inflammatory Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Non-Steroidal Anti-Inflammatory Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Non-Steroidal Anti-Inflammatory Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc. and Merck & Co., Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-Steroidal Anti-Inflammatory Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Non-Steroidal Anti-Inflammatory Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Non-Selective NSAIDs
- COX-2 Selective NSAIDs
- Dental Pain
- Muscle Aches
- Pain caused by Gout
- Bursitis
- Menstrual Cramps
- Fever
- Others
- Pfizer Inc.
- Bayer AG
- GSK plc
- Dr. Reddy’s Laboratories Ltd
- Viatris Inc
- Teva Pharmaceutical Industries Ltd.
- Johnson And Johnson Services, Inc.
- Merck & Co., Inc.
1. How big is the global Non-Steroidal Anti-Inflammatory Drugs market?
2. What is the demand of the global Non-Steroidal Anti-Inflammatory Drugs market?
3. What is the year over year growth of the global Non-Steroidal Anti-Inflammatory Drugs market?
4. What is the total value of the global Non-Steroidal Anti-Inflammatory Drugs market?
5. Who are the major players in the global Non-Steroidal Anti-Inflammatory Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Non-Steroidal Anti-Inflammatory Drugs Introduction
1.2 World Non-Steroidal Anti-Inflammatory Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Non-Steroidal Anti-Inflammatory Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.3 China Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.4 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.5 Japan Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.6 South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.7 ASEAN Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.8 India Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Steroidal Anti-Inflammatory Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-Steroidal Anti-Inflammatory Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.2 World Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region
2.2.1 World Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2023)
2.2.2 World Non-Steroidal Anti-Inflammatory Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.4 China Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.5 Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.6 Japan Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.7 South Korea Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.8 ASEAN Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.9 India Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
3 WORLD NON-STEROIDAL ANTI-INFLAMMATORY DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-Steroidal Anti-Inflammatory Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Non-Steroidal Anti-Inflammatory Drugs in 2022
3.3 Non-Steroidal Anti-Inflammatory Drugs Company Evaluation Quadrant
3.4 Non-Steroidal Anti-Inflammatory Drugs Market: Overall Company Footprint Analysis
3.4.1 Non-Steroidal Anti-Inflammatory Drugs Market: Region Footprint
3.4.2 Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
3.4.3 Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Non-Steroidal Anti-Inflammatory Drugs Consumption Value Comparison
4.2.1 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Non-Steroidal Anti-Inflammatory Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023)
4.4 China Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Non-Steroidal Anti-Inflammatory Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023)
4.5 Rest of World Based Non-Steroidal Anti-Inflammatory Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-Selective NSAIDs
5.2.2 COX-2 Selective NSAIDs
5.3 Market Segment by Type
5.3.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023)
5.3.2 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2029)
5.3.3 World Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Dental Pain
6.2.2 Muscle Aches
6.2.3 Pain caused by Gout
6.2.4 Bursitis
6.2.5 Bursitis
6.2.6 Fever
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023)
6.3.2 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2029)
6.3.3 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Details
7.1.2 Pfizer Inc. Major Business
7.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.1.4 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Inc. Recent Developments/Updates
7.1.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.2 Bayer AG
7.2.1 Bayer AG Details
7.2.2 Bayer AG Major Business
7.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.2.4 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer AG Recent Developments/Updates
7.2.6 Bayer AG Competitive Strengths & Weaknesses
7.3 GSK plc
7.3.1 GSK plc Details
7.3.2 GSK plc Major Business
7.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.3.4 GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 GSK plc Recent Developments/Updates
7.3.6 GSK plc Competitive Strengths & Weaknesses
7.4 Dr. Reddy’s Laboratories Ltd
7.4.1 Dr. Reddy’s Laboratories Ltd Details
7.4.2 Dr. Reddy’s Laboratories Ltd Major Business
7.4.3 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.4.4 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Dr. Reddy’s Laboratories Ltd Recent Developments/Updates
7.4.6 Dr. Reddy’s Laboratories Ltd Competitive Strengths & Weaknesses
7.5 Viatris Inc
7.5.1 Viatris Inc Details
7.5.2 Viatris Inc Major Business
7.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.5.4 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Viatris Inc Recent Developments/Updates
7.5.6 Viatris Inc Competitive Strengths & Weaknesses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Teva Pharmaceutical Industries Ltd. Details
7.6.2 Teva Pharmaceutical Industries Ltd. Major Business
7.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.6.4 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.6.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.7 Johnson And Johnson Services, Inc.
7.7.1 Johnson And Johnson Services, Inc. Details
7.7.2 Johnson And Johnson Services, Inc. Major Business
7.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.7.4 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Johnson And Johnson Services, Inc. Recent Developments/Updates
7.7.6 Johnson And Johnson Services, Inc. Competitive Strengths & Weaknesses
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Details
7.8.2 Merck & Co., Inc. Major Business
7.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.8.4 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Merck & Co., Inc. Recent Developments/Updates
7.8.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Non-Steroidal Anti-Inflammatory Drugs Industry Chain
8.2 Non-Steroidal Anti-Inflammatory Drugs Upstream Analysis
8.3 Non-Steroidal Anti-Inflammatory Drugs Midstream Analysis
8.4 Non-Steroidal Anti-Inflammatory Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Non-Steroidal Anti-Inflammatory Drugs Introduction
1.2 World Non-Steroidal Anti-Inflammatory Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Non-Steroidal Anti-Inflammatory Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.3 China Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.4 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.5 Japan Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.6 South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.7 ASEAN Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.3.8 India Non-Steroidal Anti-Inflammatory Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Steroidal Anti-Inflammatory Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-Steroidal Anti-Inflammatory Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.2 World Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region
2.2.1 World Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2023)
2.2.2 World Non-Steroidal Anti-Inflammatory Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.4 China Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.5 Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.6 Japan Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.7 South Korea Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.8 ASEAN Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
2.9 India Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029)
3 WORLD NON-STEROIDAL ANTI-INFLAMMATORY DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-Steroidal Anti-Inflammatory Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Non-Steroidal Anti-Inflammatory Drugs in 2022
3.3 Non-Steroidal Anti-Inflammatory Drugs Company Evaluation Quadrant
3.4 Non-Steroidal Anti-Inflammatory Drugs Market: Overall Company Footprint Analysis
3.4.1 Non-Steroidal Anti-Inflammatory Drugs Market: Region Footprint
3.4.2 Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
3.4.3 Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Non-Steroidal Anti-Inflammatory Drugs Consumption Value Comparison
4.2.1 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Non-Steroidal Anti-Inflammatory Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023)
4.4 China Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Non-Steroidal Anti-Inflammatory Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023)
4.5 Rest of World Based Non-Steroidal Anti-Inflammatory Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-Selective NSAIDs
5.2.2 COX-2 Selective NSAIDs
5.3 Market Segment by Type
5.3.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023)
5.3.2 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2029)
5.3.3 World Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Dental Pain
6.2.2 Muscle Aches
6.2.3 Pain caused by Gout
6.2.4 Bursitis
6.2.5 Bursitis
6.2.6 Fever
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023)
6.3.2 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2029)
6.3.3 World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Details
7.1.2 Pfizer Inc. Major Business
7.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.1.4 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Inc. Recent Developments/Updates
7.1.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.2 Bayer AG
7.2.1 Bayer AG Details
7.2.2 Bayer AG Major Business
7.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.2.4 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer AG Recent Developments/Updates
7.2.6 Bayer AG Competitive Strengths & Weaknesses
7.3 GSK plc
7.3.1 GSK plc Details
7.3.2 GSK plc Major Business
7.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.3.4 GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 GSK plc Recent Developments/Updates
7.3.6 GSK plc Competitive Strengths & Weaknesses
7.4 Dr. Reddy’s Laboratories Ltd
7.4.1 Dr. Reddy’s Laboratories Ltd Details
7.4.2 Dr. Reddy’s Laboratories Ltd Major Business
7.4.3 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.4.4 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Dr. Reddy’s Laboratories Ltd Recent Developments/Updates
7.4.6 Dr. Reddy’s Laboratories Ltd Competitive Strengths & Weaknesses
7.5 Viatris Inc
7.5.1 Viatris Inc Details
7.5.2 Viatris Inc Major Business
7.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.5.4 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Viatris Inc Recent Developments/Updates
7.5.6 Viatris Inc Competitive Strengths & Weaknesses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Teva Pharmaceutical Industries Ltd. Details
7.6.2 Teva Pharmaceutical Industries Ltd. Major Business
7.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.6.4 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.6.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.7 Johnson And Johnson Services, Inc.
7.7.1 Johnson And Johnson Services, Inc. Details
7.7.2 Johnson And Johnson Services, Inc. Major Business
7.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.7.4 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Johnson And Johnson Services, Inc. Recent Developments/Updates
7.7.6 Johnson And Johnson Services, Inc. Competitive Strengths & Weaknesses
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Details
7.8.2 Merck & Co., Inc. Major Business
7.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
7.8.4 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Merck & Co., Inc. Recent Developments/Updates
7.8.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Non-Steroidal Anti-Inflammatory Drugs Industry Chain
8.2 Non-Steroidal Anti-Inflammatory Drugs Upstream Analysis
8.3 Non-Steroidal Anti-Inflammatory Drugs Midstream Analysis
8.4 Non-Steroidal Anti-Inflammatory Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Non-Steroidal Anti-Inflammatory Drugs Players in 2022
Table 12. World Non-Steroidal Anti-Inflammatory Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Non-Steroidal Anti-Inflammatory Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Non-Steroidal Anti-Inflammatory Drugs Player
Table 15. Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
Table 16. Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
Table 17. Non-Steroidal Anti-Inflammatory Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Non-Steroidal Anti-Inflammatory Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Non-Steroidal Anti-Inflammatory Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share (2018-2023)
Table 23. China Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share (2018-2023)
Table 29. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Inc. Basic Information, Area Served and Competitors
Table 36. Pfizer Inc. Major Business
Table 37. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 38. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Inc. Recent Developments/Updates
Table 40. Pfizer Inc. Competitive Strengths & Weaknesses
Table 41. Bayer AG Basic Information, Area Served and Competitors
Table 42. Bayer AG Major Business
Table 43. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 44. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bayer AG Recent Developments/Updates
Table 46. Bayer AG Competitive Strengths & Weaknesses
Table 47. GSK plc Basic Information, Area Served and Competitors
Table 48. GSK plc Major Business
Table 49. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 50. GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. GSK plc Recent Developments/Updates
Table 52. GSK plc Competitive Strengths & Weaknesses
Table 53. Dr. Reddy’s Laboratories Ltd Basic Information, Area Served and Competitors
Table 54. Dr. Reddy’s Laboratories Ltd Major Business
Table 55. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 56. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Dr. Reddy’s Laboratories Ltd Recent Developments/Updates
Table 58. Dr. Reddy’s Laboratories Ltd Competitive Strengths & Weaknesses
Table 59. Viatris Inc Basic Information, Area Served and Competitors
Table 60. Viatris Inc Major Business
Table 61. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 62. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Viatris Inc Recent Developments/Updates
Table 64. Viatris Inc Competitive Strengths & Weaknesses
Table 65. Teva Pharmaceutical Industries Ltd. Basic Information, Area Served and Competitors
Table 66. Teva Pharmaceutical Industries Ltd. Major Business
Table 67. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 68. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 70. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 71. Johnson And Johnson Services, Inc. Basic Information, Area Served and Competitors
Table 72. Johnson And Johnson Services, Inc. Major Business
Table 73. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 74. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Johnson And Johnson Services, Inc. Recent Developments/Updates
Table 76. Merck & Co., Inc. Basic Information, Area Served and Competitors
Table 77. Merck & Co., Inc. Major Business
Table 78. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 79. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs Upstream (Raw Materials)
Table 81. Non-Steroidal Anti-Inflammatory Drugs Typical Customers
Table 1. World Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Non-Steroidal Anti-Inflammatory Drugs Players in 2022
Table 12. World Non-Steroidal Anti-Inflammatory Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Non-Steroidal Anti-Inflammatory Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Non-Steroidal Anti-Inflammatory Drugs Player
Table 15. Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
Table 16. Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
Table 17. Non-Steroidal Anti-Inflammatory Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Non-Steroidal Anti-Inflammatory Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Non-Steroidal Anti-Inflammatory Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share (2018-2023)
Table 23. China Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Non-Steroidal Anti-Inflammatory Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share (2018-2023)
Table 29. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Inc. Basic Information, Area Served and Competitors
Table 36. Pfizer Inc. Major Business
Table 37. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 38. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Inc. Recent Developments/Updates
Table 40. Pfizer Inc. Competitive Strengths & Weaknesses
Table 41. Bayer AG Basic Information, Area Served and Competitors
Table 42. Bayer AG Major Business
Table 43. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 44. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bayer AG Recent Developments/Updates
Table 46. Bayer AG Competitive Strengths & Weaknesses
Table 47. GSK plc Basic Information, Area Served and Competitors
Table 48. GSK plc Major Business
Table 49. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 50. GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. GSK plc Recent Developments/Updates
Table 52. GSK plc Competitive Strengths & Weaknesses
Table 53. Dr. Reddy’s Laboratories Ltd Basic Information, Area Served and Competitors
Table 54. Dr. Reddy’s Laboratories Ltd Major Business
Table 55. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 56. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Dr. Reddy’s Laboratories Ltd Recent Developments/Updates
Table 58. Dr. Reddy’s Laboratories Ltd Competitive Strengths & Weaknesses
Table 59. Viatris Inc Basic Information, Area Served and Competitors
Table 60. Viatris Inc Major Business
Table 61. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 62. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Viatris Inc Recent Developments/Updates
Table 64. Viatris Inc Competitive Strengths & Weaknesses
Table 65. Teva Pharmaceutical Industries Ltd. Basic Information, Area Served and Competitors
Table 66. Teva Pharmaceutical Industries Ltd. Major Business
Table 67. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 68. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 70. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 71. Johnson And Johnson Services, Inc. Basic Information, Area Served and Competitors
Table 72. Johnson And Johnson Services, Inc. Major Business
Table 73. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 74. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Johnson And Johnson Services, Inc. Recent Developments/Updates
Table 76. Merck & Co., Inc. Basic Information, Area Served and Competitors
Table 77. Merck & Co., Inc. Major Business
Table 78. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Services
Table 79. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs Upstream (Raw Materials)
Table 81. Non-Steroidal Anti-Inflammatory Drugs Typical Customers
LIST OF FIGURES
Figure 1. Non-Steroidal Anti-Inflammatory Drugs Picture
Figure 2. World Non-Steroidal Anti-Inflammatory Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Non-Steroidal Anti-Inflammatory Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Non-Steroidal Anti-Inflammatory Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Non-Steroidal Anti-Inflammatory Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-Steroidal Anti-Inflammatory Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-Steroidal Anti-Inflammatory Drugs Markets in 2022
Figure 27. United States VS China: Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type in 2022
Figure 31. Non-Selective NSAIDs
Figure 32. COX-2 Selective NSAIDs
Figure 33. World Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2018-2029)
Figure 34. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application in 2022
Figure 36. Dental Pain
Figure 37. Muscle Aches
Figure 38. Pain caused by Gout
Figure 39. Bursitis
Figure 40. Menstrual Cramps
Figure 41. Fever
Figure 42. Others
Figure 43. Non-Steroidal Anti-Inflammatory Drugs Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
Figure 1. Non-Steroidal Anti-Inflammatory Drugs Picture
Figure 2. World Non-Steroidal Anti-Inflammatory Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Non-Steroidal Anti-Inflammatory Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Non-Steroidal Anti-Inflammatory Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Non-Steroidal Anti-Inflammatory Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Non-Steroidal Anti-Inflammatory Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-Steroidal Anti-Inflammatory Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-Steroidal Anti-Inflammatory Drugs Markets in 2022
Figure 27. United States VS China: Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type in 2022
Figure 31. Non-Selective NSAIDs
Figure 32. COX-2 Selective NSAIDs
Figure 33. World Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2018-2029)
Figure 34. World Non-Steroidal Anti-Inflammatory Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application in 2022
Figure 36. Dental Pain
Figure 37. Muscle Aches
Figure 38. Pain caused by Gout
Figure 39. Bursitis
Figure 40. Menstrual Cramps
Figure 41. Fever
Figure 42. Others
Figure 43. Non-Steroidal Anti-Inflammatory Drugs Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
